Safety and Performance Evaluation of the Nephronyx System for the Treatment of Patients With ADHF

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 19, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

July 31, 2026

Conditions
Acute Decompensated Heart Failure
Interventions
DEVICE

Nephronyx system (Perfuser)

Temporary deployment of the Nephronyx system (Perfuser)

Trial Locations (4)

Unknown

RECRUITING

Rambam Medical Center, Haifa

RECRUITING

Shaare Zedek Medical Center, Jerusalem

RECRUITING

The Baruch Padeh Medical Center, Poriya, Poria Illit

RECRUITING

Kaplan Medical Center, Rehovot

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Nephronyx LTD

INDUSTRY

NCT05759806 - Safety and Performance Evaluation of the Nephronyx System for the Treatment of Patients With ADHF | Biotech Hunter | Biotech Hunter